| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910679884903321 |
|
|
Autore |
Jones Christopher |
|
|
Titolo |
Tax Planning Opportunities for Family Businesses in the New Regime [[electronic resource]] |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
London, : Thorogood Publishing, 2000 |
|
|
|
|
|
|
|
ISBN |
|
1-280-23355-9 |
9786610233557 |
1-4237-2143-8 |
1-85418-588-8 |
|
|
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (86 p.) |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Business and economics -- Corporate & business |
Tax planning |
Tax |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di contenuto |
|
The author; Contents; Introduction; Chapter 1: Incorporation of the family business; Chapter 2: Extraction of profits from the family company; Chapter 3: One man service company; Chapter 4: Expanding and structuring the business; Chapter 5: Exit routes |
|
|
|
|
|
|
|
|
Sommario/riassunto |
|
Draws attention to potential problems and provides practical advice and solutions on how to overcome them. This book deals with important planning opportunities relevant to the family concern and is aimed to be of particular use to accountants and others who regularly act for and give advice to owner-managed businesses. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2. |
Record Nr. |
UNINA9910791703203321 |
|
|
Titolo |
Chronic inflammation : molecular pathophysiology, nutritional and therapeutic interventions / / edited by Sashwati Roy, Debasis Bagchi, Siba P. Raychaudhuri |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Boca Raton : , : CRC Press, , 2013 |
|
|
|
|
|
|
|
ISBN |
|
0-429-10987-3 |
1-138-19955-9 |
1-4398-7215-5 |
|
|
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (463 p.) |
|
|
|
|
|
|
Altri autori (Persone) |
|
RoySashwati |
BagchiDebasis <1954-> |
RaychaudhuriSiba P |
|
|
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Inflammation - Treatment |
Anti-inflammatory agents |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references and index. |
|
|
|
|
|
|
Nota di contenuto |
|
Front Cover; Contents; Preface; Editors; Contributors; Chapter 1 - At the Interface between Acute and Chronic Inflammation: Insights from Computational Modeling; Chapter 2 - The Cellular Component of Chronic Inflammation; Chapter 3 - Mast Cells in Chronic Inflammation; Chapter 4 - Hypoxia and Hypoxia-Inducible Factor in Inflammation; Chapter 5 - Bioactive Phospholipid Mediators of Inflammation; Chapter 6 - Hematopoietic Stem Cells in Atherosclerotic Development and Resolution; Chapter 7 - Inflammation as a Confounding Factor in Regenerative Medicine |
Chapter 8 - NOX in the CNS: Inflammation and BeyondChapter 9 - Resolution of Inflammation; Chapter 10 - H2S in Inflammation; Chapter 11 - Is There a Connection between Inflammation and Oxidative Stress?; Chapter 12 - Chronic Inflammation and Cancer: A Matter of Lifestyle; Chapter 13 - Chronic Wounds and Inflammation; Chapter 14 - Multiphasic Roles for TGF-Beta in Scarring: Implications for Therapeutic Intervention; Chapter 15 - Natural Vitamin E Tocotrienol against Neuroinflammation and Oxidative Stress; Chapter 16 - Inflammatory |
|
|
|
|
|
|
|
|
|
|
|
Cascades in Autoimmune Disease |
Chapter 17 - Shear Stress and Vascular Inflammation: A Study in the LungChapter 18 - NGF and Its Receptor System in Inflammatory Diseases; Chapter 19 - Inflammation, Oxidative Stress, and Antioxidants; Chapter 20 - Lipid Biomarkers of Inflammation; Chapter 21 - Physical Activity and Inflammation: An Overview; Chapter 22 - Omega-6 and Omega-3 Polyunsaturated Fatty Acids and Inflammatory Processes; Chapter 23 - Anti-Inflammatory Phytochemicals, Obesity, and Diabetes: An Overview; Chapter 24 - Anti-Inflammatory Nutraceuticals and Herbal Medicines for the Management of Metabolic Syndrome |
Chapter 25 - Epigenetics and Nutriepigenomics in Chronic Inflammatory Lung Diseases: Nutritional and Therapeutic InterventionsChapter 26 - Biologics: Molecular Medicine from Bench to Bedside; Chapter 27 - Disease Modifying Anti-Rheumatic Drugs; Chapter 28 - Nonsteroidal Anti-Inflammatory Drugs; Back Cover |
|
|
|
|
|
|
Sommario/riassunto |
|
Although acute inflammation is a healthy physiological response indicative of wound healing, chronic inflammation has been directly implicated in a wide range of degenerative human health disorders encompassing almost all present day non-communicable diseases including autoimmune diseases, obesity, diabetes and atherosclerosis. Chronic Inflammation: Molecular Pathophysiology, Nutritional and Therapeutic Interventions provides an exposition of the process of chronic inflammation in three parts:Systems Biology of Inflammation and Regulatory Mechanisms |
|
|
|
|
|
|
|
| |